[The Effects of Decitabine Combined with All-Trans Retinoic Acid on the Number of Immune Cells in Myeloid Neoplasms].

Wei Wei, Yue Liu, Limei Shang, Yang Cao, Fei Wang, Yanting Guo, Rongrong Lin, Yan Lin, Weimin Dong, Weiying GuPubMed 2022 · DOI

Abstract

The efficacy of DEC/ATRA on myeloid neoplasms is comparable to that of DEC/priming regimen, and the anti-myeloid tumor effect of DEC/ATRA regimen may be related to the regulation of NK cells and T cells.
BibTeX
@inproceedings{wei2022effects,
  author = {Wei Wei and Yue Liu and Limei Shang and Yang Cao and Fei Wang and Yanting Guo and Rongrong Lin and Yan Lin and Weimin Dong and Weiying Gu},
  title = {{[The Effects of Decitabine Combined with All-Trans Retinoic Acid on the Number of Immune Cells in Myeloid Neoplasms].}},
  booktitle = {PubMed},
  year = {2022},
  doi = {10.19746/j.cnki.issn.1009-2137.2022.01.002},
}

Loading related content...

Figure